Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Research and Innovation Action · Running

WISDOM Well-being improvement through the Integration of healthcare and reSearch Data and models with Out border for chronic iMmune-mediated diseases

Coordinator
Karolinska Institutet, Sweden
Runs
1 December 2023 to 30 November 2028
Status
Running
EU funding
€9.6m
Total cost
€9.6m
Partners
15 organisations in 10 countries
Type
Research and Innovation Action
Grant agreement
101137154

What the project is doing

In the project's own words, from its summary on CORDIS.

Enabling integration of medical and research data, secure data sharing and leveraging responsible state-of-the-art artificial intelligence (AI)-mediated models opens immense possibilities to mitigate the impact of chronic immune-mediated diseases (CIMDs) affecting 10% of Europeans. Eight European universities, leaders in the medical and analytical field, three SMEs, one research institute and one company, at the forefront of clinical AI implementation, data infrastructure, and security, and a Patient Organisation formed the consortium WISDOM.

The consortium's overarching aim is to convert complex biological information from the existing data sources into actionable insights. WISDOM builds on the premise that computational tools can provide valuable knowledge and guide decision-making at critical stages in the individual patient journey, from diagnosis to treatment initiation and optimisation. To unlock the potential of the existing data, WISDOM will address barriers of data integration and accessibility and deploy novel approaches for data processing, harmonisation, integration, and secure, trustworthy data sharing with federated access.

WISDOM aims to develop computational risk stratification and outcome prediction models and tools in different CIMD use cases, building on large EU-funded multimodal datasets, and prospectively validate them on technical, clinical and user aspects to facilitate data-driven and patient-focused diagnosis, treatment, and monitoring. WISDOM aims to promote the widespread utilisation of data and facilitate responsible and critical assessment of the use of AI in healthcare using an end-user guided approach leveraging collaboration among clinicians, researchers, legal and AI experts, patient associations and rich stakeholder expertise.

WISDOM’s ultimate ambition is to revolutionise the integration, management, and analysis of health data across diseases and borders to promote personalised interventions and well-being.

Topics

Who is involved

OrganisationCityCountryRole
Karolinska InstitutetStockholmSwedenCoordinator
The European Multiple Sclerosis Platform AisblBruxelles / BrusselBelgiumParticipant
Klinikum Der Technischen Universität München (tum Klinikum)MuenchenGermanyParticipant
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Syddansk UniversitetOdense MDenmarkParticipant
Tartu UlikoolTartuEstoniaParticipant
Fundacio Centre De Regulacio GenomicaBarcelonaSpainParticipant
Helsingin YliopistoHelsinkiFinlandParticipant
Veil.ai OyHelsinkiFinlandParticipant
Islensk Erfdagreining EhfReykjavikIcelandParticipant
Universita Degli Studi Del Piemonte Orientale Amedeo AvogadroVercelliItalyParticipant
Karolinska Institutet Innovations ABSolnaSwedenParticipant
Region StockholmStockholmSwedenThird party
Yh Youhealth ABStockholmSwedenParticipant
The Chancellor Masters and Scholars of the University of CambridgeCambridgeUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI